Labroots
Home  >  News

Filter your search

Clear All Filters

Absave Filter Sale Labsave Facebook Like Us Absave Newsletter Signup Filter

News

New product from Maine Biotechnology Services, Inc.
New product from Maine Biotechnology Services, Inc.
Maine Biotechnology Services
08/07/2014

MAB241P Monoclonal Antibody to Glutathione S-Transferase (GST) •    Reactivity with  N or C terminal GST fusion proteins in WB      •    Developed and produced at Maine Biotechnology Services •     Lot to lot consistency, and competitive pricing guaranteedMAB241P 100µg Sample for only $75.00
NEW from MBS R&D, Monoclonal Antibodies to Cystatin C
NEW from MBS R&D, Monoclonal Antibodies to Cystatin C
Maine Biotechnology Services
17/09/2013

MBS is pleased to release three new monoclonal antibodies to Cystatin C, available in two matched pair combinations. The pairs have proven sensitive enough to detect Cystatin C present in serum and purified from urine in the ng/mL range. As always, these antibodies were developed and produced at MBS to allow for extensive product support and maximum price flexibility for bulk sales.
MBS HIS-tag antibody MAB230P Chosen for 2nd Generation  Forte BIO Dip and Read™ Anti-HIS (HIS2) Biosensors
MBS HIS-tag antibody MAB230P Chosen for 2nd Generation Forte BIO Dip and Read™ Anti-HIS (HIS2) Biosensors
Maine Biotechnology Services
20/08/2013

Best Value in the MarketplaceHighly Specific: Does not bind to E. coli host cell proteinsExcellent Sensitivity: Detects nanogram quantities of HIS-tagged proteinsReliability:  Minimal lot to lot variabilityStrong Affinity: 8.85 x 10-12 M by Forte Bio Octet RedBroadly Reactive: Recognizes (HIS)-tags of 4X or greater engineered at either the N- or C- terminus of the protein
MBS Announces Expansion of Custom Services to Include Assay Development
MBS Announces Expansion of Custom Services to Include Assay Development
Maine Biotechnology Services
16/01/2013

Assay Development Service    In response to customer inquiries, MBS announces the expansion of contract services offered to include ELISA development.  The assay development service will provide customers with refined, R&D use assays at the end of hybridoma development.   Optimization of reagents for assay applications has long been an area of core competency for MBS, used heavily in the development of internal products and services. It is...